Search

Your search keyword '"Verzenio (Medication)"' showing total 9 results
Start Over Descriptor "Verzenio (Medication)" Search Limiters Full Text
9 results on '"Verzenio (Medication)"'

1. Australia : New hope to treat women with early breast cancer

Subjects
Women, Diseases -- Relapse, Breast cancer -- Care and treatment, Business, international, Verzenio (Medication)
Abstract

For the first time in 15-years women with an invasive form of early breast cancer that has a high risk of returning after initial treatment will now have access to [...]

Published
2024

2. Switzerland : New CDK4|6i data at ASCO reinforce Novartis Kisqali as only drug in class with consistently proven overall survival benefit in HR+|HER2- metastatic breast cancer

Subjects
Postmenopausal women -- Patient outcomes -- Drug therapy, Metastasis -- Patient outcomes -- Drug therapy, Breast cancer -- Drug therapy -- Patient outcomes, Fulvestrant -- Analysis, Business, international, Verzenio (Medication), Kisqali (Medication)
Abstract

Kisqali is the only CDK4/6 inhibitor with consistent overall survival (OS) benefit seen across all three Phase III trials, with the longest median OS benefit ever reported for HR+/HER2- mBC1-10 [...]

Published
2022

3. Australia : Breast cancer treatment expanded on the Pharmaceutical Benefits Scheme

Subjects
Antineoplastic agents, Cancer -- Care and treatment, Breast cancer -- Drug therapy, Antimitotic agents, Business, international, Verzenio (Medication)
Abstract

The Morrison Government is helping improve access to an important treatment for Australians battling a form of breast cancer. From 1 November 2021, the Pharmaceutical Benefits Scheme (PBS) listing of [...]

Published
2021

4. Onco360 Selected for VERZENIO[R] Limited Distribution Pharmacy Network

Subjects
United States. Food and Drug Administration, Eli Lilly and Co., Women's health, Pharmacy, Pharmaceutical industry, Drug approval, Drug wholesalers, Health, Women's issues/gender studies, Verzenio (Medication)
Abstract

2017 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Onco360, the nation's largest independent Oncology Pharmacy, announced that it has been selected to [...]

Published
2017

5. Australia : New hope for breast cancer patients with key drug added to PBS

Subjects
Abemaciclib, Cancer patients -- Drug therapy, Breast cancer -- Drug therapy, Epidermal growth factors, Time, Hormones, Retirement benefits, Menopause, Business, international, Verzenio (Medication)
Abstract

Australians living with advanced breast cancer now have access to an important new treatment option, with the Morrison Government listing a life-changing new medicine on the Pharmaceutical Benefits Scheme (PBS). [...]

Published
2020

6. United States : Verzenio Significantly Extends Life by a Median of 9.4 Months for Women with HR+, HER2- Advanced Breast Cancer in MONARCH 2 Study

Subjects
Eli Lilly and Co., Cancer research, Postmenopausal women, Fulvestrant, Pharmaceutical industry, Abemaciclib, Breast cancer, Epidermal growth factors, Hormones, Conferences and conventions, Clinical trials, Cancer metastasis, Business, international, Verzenio (Medication)
Abstract

Eli Lilly and Company announced Verzenio (abemaciclib) in combination with fulvestrant significantly extended life by a median of 9.4 months in women with hormone receptor-positive (HR+), human epidermal growth factor [...]

Published
2019

7. United States : Lilly Oncology to Present Robust Data across Its Growing Portfolio at ESMO 2019

Subjects
Eli Lilly and Co., Fulvestrant, Pharmaceutical industry, Abemaciclib, Cancer, Patient care, Cancer patients, Business, international, Verzenio (Medication)
Abstract

Eli Lilly and Company (NYSE: LLY) today announced data from a number of studies across the company's oncology product portfolio will be presented at the European Society for Medical Oncology [...]

Published
2019

8. Canada : Health Canada approves new drug to treat metastatic breast cancer through international and domestic joint reviews

Subjects
Drug approval, Breast cancer -- Care and treatment, Drugs, Cancer metastasis -- Care and treatment, Abemaciclib, Canadians, Health, Business, international, Verzenio (Medication)
Abstract

Canadians want improved access to the most recent and innovative treatment options for themselves and their families. To help bring new treatments to Canada, Health Canada is partnering with other [...]

Published
2019

9. Verzenio NDA receives Priority Review from FDA

Subjects
United States. Food and Drug Administration, Verzenio (Medication), Drug therapy, Drug approval
Abstract

The Food and Drug Administration has granted Eli Lilly and Co. Priority Review designation for its New Drug Application (NDA) for Verzenio (abemaciclib), a cyclin-dependent kinase (CDK) 4 & 6 [...]

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results